Gemifloxacin Mesylate

甲磺酸吉米沙星

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGemifloxacin Mesylate
Drug Alias Name吉米沙星gemifloxacinumgemifloxacinoGemifloxacin mesilate吉速星 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsCommunity Acquired PneumoniaBronchitis, ChronicCommunicable Diseases +[4] 
Global Approved IndicationsCommunity Acquired PneumoniaBronchitis, ChronicBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date2003/04/04
Country/TerritoryUnited StatesSouth KoreaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLg Chemical Ltd
Active IndicationsBacterial Infections
Inactive IndicationsCommunity Acquired PneumoniaBronchitis, ChronicCommunicable Diseases

Other Information

ATC CodeJ01MA15
Related LinksWikipediaDrugBankKEGG